Media releases & statements

April

Seven Day Slim Capsules

8 April 2020

Seven Day Slim capsules pose a serious risk to your health and should not be taken.
Vigour 800 tablets

8 April 2020

Vigour 800 tablets pose a serious risk to your health and should not be taken.
Coronavirus (COVID-19): Information on medicines and medical devices

7 April 2020

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page
Amendments to the new restrictions on prescribing hydroxychloroquine for COVID-19

6 April 2020

From 3 April 2020, dental board practitioners have been added to the list of specialist health practitioners
Mojo Black capsules

3 April 2020

Mojo Black capsules pose a serious risk to your health and should not be taken
ATP Science issued infringement notices for $302,400 for alleged advertising breaches

3 April 2020

The TGA has issued ATP Science Pty Ltd with 24 infringement notices
Ranitidine

2 April 2020

Update 2 - contamination with N-nitrosodimethylamine
Warning to consumers and advertisers about COVID-19 test kits

1 April 2020

COVID-19 tests must be done under the direction of a health professional
Seasonal flu vaccine (all alerts)

1 April 2020

Information about seasonal flu vaccines
Influenza vaccines released for 2020 season

1 April 2020

Six influenza vaccines are available in Australia in 2020
Gentamicin 40 mg/mL Injection (Hospira UK Limited)

1 April 2020

Safety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation

March

Oxymed Australia Pty Ltd fined $63,000 for alleged advertising breaches

27 March 2020

The TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches
No evidence to support intravenous high-dose vitamin C in the management of COVID-19

27 March 2020

We have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19
TGA issues warning about illegal advertising relating to COVID-19

24 March 2020

The TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19
New restrictions on prescribing hydroxychloroquine for COVID-19

24 March 2020

Only certain types of specialists will be able to prescribe hydroxychloroquine to new patients
COVID-19 advice on surgical masks and gowns

23 March 2020

Information relating to surgical masks and gowns to assist healthcare organisations as they update their operating procedures during the outbreak
No evidence to support claims ibuprofen worsens COVID-19 symptoms

20 March 2020

TGA monitoring
Supplying COVID-19 tests

20 March 2020

Information for sponsors regarding the supply of COVID-19 tests
COVID-19 limits on dispensing and sales at pharmacies

19 March 2020

Information for consumers
Limits on dispensing and sales of prescription and over-the-counter medicines

19 March 2020

Community pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines
TGA response to coronavirus (COVID-19)

19 March 2020

Information updated to include details about good manufacturing practice for sponsors and manufacturers
TGA suspends overseas GMP inspections and QMS audits until further notice

19 March 2020

Due to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice
TGA cautions against over-buying medicines

16 March 2020

Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies
2020 seasonal influenza vaccines

13 March 2020

Information for consumers and health professionals
Dragon 'Wolverine' tablets

13 March 2020

Dragon 'Wolverine' tablets pose a serious risk to your health and should not be taken
Court proceedings commenced against Evolution Supplements Australia and its sole director for alleged advertising breaches

13 March 2020

The Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia (Court) against Evolution Supplements Australia Pty Ltd
Maxman Cialis tablets (Plastic bottle inside cardboard carton)

6 March 2020

Maxman Cialis Tablets pose a serious risk to your health and should not be taken
International work-sharing initiative - Baloxavir marboxil (Xofluza)

5 March 2020

Xofluza approved as part of an international work-sharing initiative between the TGA, Health Canada and Swissmedic

February

Caruso’s Natural Health fined $12,600 for falsely claiming to hold evidence for Caruso’s Kids Eye Care

26 February 2020

Caruso's Natural Health pays $12,600 fine for false certification in relation to therapeutic good
Bling Bling Sister BBS Superman Capsules

26 February 2020

Bling Bling Sister BBS Superman capsules pose a serious risk to your health and should not be taken
Multi-level marketing company fined $37,800 for alleged advertising breaches

18 February 2020

Juice Plus Company Australia Pty Ltd has paid penalties of $37,800 for alleged advertising breaches relating to vitamin products
Palexia SR 100 mg tapentadol sustained release tablets

14 February 2020

Product defect correction - potential for blank labelling to pose risk of accidental misuse
InSkin Cosmedics Group pays $37,800 in penalties for alleged supply and advertising of unapproved dermapen device

10 February 2020

InSkin Cosmedics Group Pty Ltd has paid penalties of $37,800 in regards to the alleged supply and advertising of the Dermapen 4
Warning about products claiming to treat or prevent the novel coronavirus

7 February 2020

The TGA has identified certain therapeutic goods being inappropriately promoted for the prevention or treatment of novel coronavirus (2019-nCoV) infections in Australia
Prescription opioids hub

4 February 2020

New information for industry added

January

Measles vaccines available in Australia continue to meet quality standards

22 January 2020

Measles vaccine testing shows the vaccine meets required standards
No shortage of salbutamol asthma inhalers

10 January 2020

Adequate stock available despite bushfires
Temporary permission granted to advertise puffers and other inhalers with salbutamol

7 January 2020

Pharmacies and others can advertise availability of OTC salbutamol products during the bushfire season

You are here

Media releases & statements

Related information

Current year media releases & statements

Historical media releases & statements